U.S. Catholic bishops will gather Nov. 16 and 17 for their annual meeting, but this time in an online format because of the coronavirus pandemic.
U.S. Catholic bishops will gather Nov. 16 and 17 for their annual meeting, but this time in an online format because of the coronavirus pandemic.
Louisiana and Colorado voted opposite ways on different abortion measures that appeared on each state’s ballot Nov. 3.
Bishops in the United States and around the world expressed condolences after three people were murdered before Mass Oct. 29 in the basilica in Nice, France.
The chairmen of two U.S. bishops’ committees said Oct. 27 that companion bills in the House and Senate are needed measures to protect athletic programs designated for women and girls at educational institutions that receive Title IX funds for these programs.
The annual Ignatian Family Teach-in for Justice, the largest Catholic social justice gathering in the United States, is known for dispensing sharp opinions.
The chairman of the U.S. bishops’ Committee on Religious Liberty praised the Department of Health and Human Services for resolving discrimination complaints over two hospitals’ refusal to let patients have access to the sacraments of baptism and the anointing of the sick during the COVID-19 pandemic.
The Catholic voter “bears responsibility for connecting the dots between what our faith teaches and which candidates will best serve the common good,” Bishop W. Shawn McKnight of Jefferson City said in a recent column for The Catholic Missourian, the diocesan newspaper.
As Catholics around the country prepare to cast their votes for president, the United States Conference of Catholic Bishops (USCCB) has announced that it will be holding a virtual “Elections Novena” from Oct. 26 – Nov. 4.
Catholic bioethicists express concern about developing COVID-19 vaccines or therapeutics using cell lines created from fetuses aborted nearly five decades ago. One such drug was praised recently by President Donald Trump, who said it cured him from his recent bout with COVID-19.
The treatment that President Donald Trump has received to fight COVID-19 has turned the focus on an experimental drug that shows promise in combating the coronavirus but is raising ethical questions about the cell line that helped researchers develop the medicine.